• 1. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 2. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 3. An Aptamer Bio-barCode (ABC) assay using SPR, RNase H, and probes with RNA and gold-nanorods for anti-cancer drug screening
  Chengbin Yang,Hing Lun Tsang,Pui Man Lau,Ken-Tye Yong,Ho Pui Ho,Siu Kai Kong Analyst, 2017,142, 3579-3587
• 4. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 5. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines

Introduction to N-methyl-N-(piperidin-4-yl)acetamide (CAS No. 83180-55-6)

N-methyl-N-(piperidin-4-yl)acetamide, a compound with the chemical identifier CAS No. 83180-55-6, is a significant molecule in the field of pharmaceutical chemistry and biochemistry. This compound belongs to the class of amides, which are widely recognized for their diverse biological activities and roles in drug development. The structural features of N-methyl-N-(piperidin-4-yl)acetamide make it a promising candidate for further investigation in various therapeutic applications.

The molecular structure of N-methyl-N-(piperidin-4-yl)acetamide consists of a piperidine ring linked to an acetamide moiety. The piperidine ring is a six-membered heterocyclic compound containing one nitrogen atom, which is known for its ability to enhance the solubility and bioavailability of pharmaceutical compounds. The acetamide group, on the other hand, contributes to the compound's amide functionality, which is crucial for its interactions with biological targets. This combination of structural elements makes N-methyl-N-(piperidin-4-yl)acetamide a versatile scaffold for drug discovery.

In recent years, there has been growing interest in the development of novel compounds based on piperidine derivatives due to their potential pharmacological properties. Research has shown that piperidine-containing molecules can exhibit a wide range of biological activities, including antimicrobial, anti-inflammatory, and anticancer effects. The presence of the acetamide group further enhances these properties by facilitating hydrogen bonding interactions with biological targets.

One of the most exciting areas of research involving N-methyl-N-(piperidin-4-yl)acetamide is its application in the development of kinase inhibitors. Kinases are enzymes that play a critical role in cell signaling pathways and are often implicated in various diseases, including cancer. By designing molecules that can selectively inhibit specific kinases, researchers aim to develop targeted therapies that can effectively treat these conditions without causing significant side effects.

Recent studies have demonstrated that N-methyl-N-(piperidin-4-yl)acetamide can serve as a lead compound for the development of potent kinase inhibitors. These studies have shown that derivatives of this compound can bind to the active site of kinases, thereby blocking their activity. This has led to the identification of several promising candidates for further development into therapeutic agents. The ability of N-methyl-N-(piperidin-4-yl)acetamide to interact with kinases has also raised interest in its potential use for treating other diseases associated with abnormal kinase activity.

Another area where N-methyl-N-(piperidin-4-yl)acetamide shows promise is in the treatment of neurological disorders. Piperidine derivatives have been found to cross the blood-brain barrier, making them suitable for treating central nervous system (CNS) disorders. Research has indicated that compounds like N-methyl-N-(piperidin-4-yl)acetamide can modulate neurotransmitter systems, potentially leading to new treatments for conditions such as depression, anxiety, and Parkinson's disease.

The synthesis of N-methyl-N-(piperidin-4-yl)acetamide involves several steps that require careful optimization to ensure high yield and purity. The process typically starts with the reaction of piperidine with acetic anhydride or methyl acetoacetate to form the corresponding piperidine derivative. This intermediate is then treated with methylamine or another amine source to introduce the amide group. The final step involves purification techniques such as recrystallization or column chromatography to obtain pure N-methyl-N-(piperidin-4-yl)acetamide.

The pharmacokinetic properties of N-methyl-N-(piperidin-4-yl)acetamide are also an important consideration in its development as a drug candidate. Studies have shown that this compound exhibits good oral bioavailability and moderate metabolic stability, making it suitable for further clinical investigation. Additionally, its solubility profile suggests that it may be suitable for formulation into various dosage forms, including tablets and capsules.

In conclusion, N-methyl-N-(piperidin-4-yl)acetamide (CAS No. 83180-55-6) is a promising compound with significant potential in pharmaceutical research and development. Its unique structural features and biological activities make it a valuable scaffold for designing novel therapeutic agents. Further research is needed to fully explore its pharmacological properties and potential applications in treating various diseases.

• 139062-96-7(1-[4-(methylamino)piperidin-1-yl]ethan-1-one)
• 856846-18-9(Acetamide,N-(1-acetyl-4-piperidinyl)-)
• 71879-46-4(1-(4-(Methylamino)piperidin-1-yl)ethanone hydrochloride)
• 497838-40-1(1-(4-(Dimethylamino)piperidin-1-yl)ethanone)
• 387358-46-5(1-4-(Cyclopropylamino)piperidin-1-ylethan-1-one)
• 71872-49-6(1-(4-(Methylamino)piperidin-1-yl)ethanone hydrochloride)
• 88535-88-0(1-(4-(Ethylamino)piperidin-1-yl)ethanone)
• 793662-76-7(1-[endo-3-amino-8-azabicyclo[3.2.1]octan-8-yl]ethanone)
• 71872-19-0(1-(4-(Methylamino)piperidin-1-yl)ethanone hydrochloride)
• 859522-16-0(1-4-(cyclohexylamino)piperidin-1-ylethan-1-one)